Literature DB >> 12925877

Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Ralph Feuer1, Ignacio Mena, Robb R Pagarigan, Daniel E Hassett, J Lindsay Whitton.   

Abstract

Coxsackieviruses (CV) are characterized by their ability to cause cytopathic effects in tissue culture and by their capacity to initiate acute disease by inducing apoptosis within targeted organs in vivo. These viruses are considered highly cytolytic, but can establish persistence/latency in susceptible cells, indicating that a regulatory mechanism may exist to shut off viral protein synthesis and replication under certain situations. The persistence of coxsackieviral RNA is of particular medical interest due to its association with chronic human diseases such as dilated cardiomyopathy and chronic inflammatory myopathy. Here, we discuss the potential mechanisms regulating coxsackievirus replication, and the ability of viral RNA to remain in an apparent latent state within quiescent cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925877     DOI: 10.1007/s00430-003-0192-z

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  47 in total

1.  Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines.

Authors:  Jie Zhang; Nicole Silvestri; J Lindsay Whitton; Daniel E Hassett
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  New neuromuscular symptoms after old polio ("the post-polio syndrome"): clinical studies and pathogenetic mechanisms.

Authors:  M C Dalakas
Journal:  Birth Defects Orig Artic Ser       Date:  1987

Review 3.  The group B coxsackieviruses and myocarditis.

Authors:  K S Kim; G Hufnagel; N M Chapman; S Tracy
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

4.  High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China.

Authors:  Y Li; T Peng; Y Yang; C Niu; L C Archard; H Zhang
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

5.  A cell cycle-dependent internal ribosome entry site.

Authors:  S Pyronnet; L Pradayrol; N Sonenberg
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

6.  Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes.

Authors:  R Wessely; A Henke; R Zell; R Kandolf; K U Knowlton
Journal:  Circulation       Date:  1998-08-04       Impact factor: 29.690

7.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  New neuromuscular symptoms in patients with old poliomyelitis: a three-year follow-up study.

Authors:  M C Dalakas
Journal:  Eur Neurol       Date:  1986       Impact factor: 1.710

9.  Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.

Authors:  Mary Anne Opavsky; Tami Martino; Marlene Rabinovitch; Josef Penninger; Chris Richardson; Martin Petric; Cathy Trinidad; Lisa Butcher; Janice Chan; Peter P Liu
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products.

Authors:  L C Archard; M A Khan; B A Soteriou; H Zhang; H J Why; N M Robinson; P J Richardson
Journal:  Hum Pathol       Date:  1998-06       Impact factor: 3.466

View more
  15 in total

1.  The anti-obesity drug orlistat reveals anti-viral activity.

Authors:  Elisabeth Ammer; Sandor Nietzsche; Christian Rien; Alexander Kühnl; Theresa Mader; Regine Heller; Andreas Sauerbrei; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2015-02-14       Impact factor: 3.402

2.  Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.

Authors:  A Kühnl; C Rien; K Spengler; N Kryeziu; A Sauerbrei; R Heller; A Henke
Journal:  Med Microbiol Immunol       Date:  2014-03-11       Impact factor: 3.402

3.  A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS.

Authors:  Jenna M Tabor-Godwin; Chelsea M Ruller; Nolan Bagalso; Naili An; Robb R Pagarigan; Stephanie Harkins; Paul E Gilbert; William B Kiosses; Natalie A Gude; Christopher T Cornell; Kelly S Doran; Mark A Sussman; J Lindsay Whitton; Ralph Feuer
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

4.  Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.

Authors:  E K Alidjinou; I Engelmann; J Bossu; C Villenet; M Figeac; M-B Romond; F Sané; D Hober
Journal:  Virulence       Date:  2017-01-23       Impact factor: 5.882

5.  S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells.

Authors:  Anna-Marija Helt; Eva Harris
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  MicroRNA-324-3p Plays A Protective Role Against Coxsackievirus B3-Induced Viral Myocarditis.

Authors:  Tingjun Liu; Jing Tong; Chen Shao; Junyan Qu; Hua Wang; Yi Shi; Yajing Lin; Yun Liu; Shihe Shao; Hongxing Shen
Journal:  Virol Sin       Date:  2021-10-11       Impact factor: 6.947

7.  Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility.

Authors:  S A Huber; M Rincon
Journal:  Virology       Date:  2008-09-30       Impact factor: 3.616

8.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

9.  Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.

Authors:  Nadine Althof; J Lindsay Whitton
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

10.  Human enterovirus species B in ileocecal Crohn's disease.

Authors:  Niklas Nyström; Tove Berg; Elin Lundin; Oskar Skog; Inga Hansson; Gun Frisk; Ivana Juko-Pecirep; Mats Nilsson; Ulf Gyllensten; Yigael Finkel; Jonas Fuxe; Alkwin Wanders
Journal:  Clin Transl Gastroenterol       Date:  2013-06-27       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.